Carvedilol could be the poster child for how to lower drug prices. Since 2007, over 20 million patients with cardiovascular conditions have enjoyed generic versions of the popular beta-blocker, which ...
High blood pressure affects nearly 50% of all American adults, an estimated 46.7%—and new high blood pressure guidelines, released earlier this month by the American Heart Association and the American ...
A low-dose regimen of the blood pressure medication carvedilol demonstrated safety and efficacy in improving heart health of childhood cancer survivors, according to results of a multicenter phase 2b ...
Cardiac arrhythmias following myocardial infarction (MI) predict poor outcome. β-blockers are effective ventricular antiarrhythmics and angiotensin-converting-enzyme (ACE) inhibitors can prevent both ...
Results suggest that more childhood cancer survivors may benefit from a heart-saving medication called carvedilol, even long after their cancer treatment is over LOS ANGELES--(BUSINESS ...
The Supreme Court declined to hear Teva's challenge to a $235 million award to GlaxoSmithKline in a patent dispute over generic drugs involving heart medication Coreg, according to a Reuters report.
The U.S. Court of Appeals for the Federal Circuit sided with a jury’s 2017 finding that Teva swayed doctors away from using GlaxoSmithKline’s drug Coreg (carvedilol) for a use of its drug that was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback